Resources from the same session
Do different sources of data matter? Comparing real-world evidence and clinical trial findings
Presenter: Luís Castelo-Branco
Session: AiCME (supported by Bayer) - Navigating new frontiers: Real world evidence's trial in advancing later-line gastrointestinal cancer therapy
Resources:
Webcast
Evaluating RWE in GI cancers: Later-line evidence for TKIs (part 2)
Presenter: Gerald Prager
Session: AiCME (supported by Bayer) - Navigating new frontiers: Real world evidence's trial in advancing later-line gastrointestinal cancer therapy
Resources:
Webcast
Patient selection in the real world: The correct TKI for the correct patient
Presenter: Luís Castelo-Branco
Session: AiCME (supported by Bayer) - Navigating new frontiers: Real world evidence's trial in advancing later-line gastrointestinal cancer therapy
Resources:
Webcast
Applying RWE to clinical practice: How does it inform later-line therapy for GI cancers?
Presenter: Luís Castelo-Branco
Session: AiCME (supported by Bayer) - Navigating new frontiers: Real world evidence's trial in advancing later-line gastrointestinal cancer therapy
Resources:
Webcast
Conclusion: Audience Q&A and closing remarks
Presenter: Luís Castelo-Branco
Session: AiCME (supported by Bayer) - Navigating new frontiers: Real world evidence's trial in advancing later-line gastrointestinal cancer therapy
Resources:
Webcast